Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma
NCT03284775 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2023-11-29
Summary
Pituitary adenoma can be difficult to cure with approximately a third of patients in contemporary series' undergoing incomplete resection. Over the last decade or so a handful of groups have described the use intraoperative ultrasound to improve resection. Although limited, these proof-of-concept studies suggest intraoperative ultrasound is a safe and effective technological adjunct to transsphenoidal surgery for pituitary adenoma.
In this prospective development study 30 adult patients will undergo transsphenoidal surgery for pituitary adenoma with prototype intraoperative ultrasound devices. The primary outcomes will be technical feasibility and device safety. The secondary outcomes will be complete versus incomplete radiological resection, endocrinological remission, the occurrence of postoperative complications, operating time, and length of stay.
Conditions
- Pituitary Adenoma
Interventions
- DEVICE
-
Intraoperative ultrasound
Patients will undergo transsphenoidal surgery in the usual manner except that an intraoperative ultrasound device will be available for use to better visualise the tumour and surrounding neurovascular structures.
Sponsors & Collaborators
-
University College, London
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-07
- Primary Completion
- 2022-08-03
- Completion
- 2023-08-02
Countries
- United Kingdom
Study Locations
More Related Trials
-
Surgical Debulking of Pituitary Adenomas
NCT01371643 ·Status: COMPLETED ·Phase: PHASE4
-
Hydrocortisone Use During Peri-operation for Pituitary Adenomas
NCT04621565 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
NCT02705014 ·Status: UNKNOWN ·Phase: NA
-
Prospective Quality of Life Study in Pituitary Surgery
NCT03694990 ·Status: UNKNOWN
-
Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity
NCT01028742 ·Status: COMPLETED
-
Seoul National University Pituitary Disease Cohort Study
NCT03474601 ·Status: UNKNOWN
-
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
NCT02288962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
NCT06435195 ·Status: RECRUITING
-
Transsphenoidal Extent of Resection Study
NCT02357498 ·Status: COMPLETED ·Phase: NA
-
DDAVP for Pituitary Adenoma
NCT04569591 ·Status: RECRUITING ·Phase: NA
-
Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery
NCT05149495 ·Status: UNKNOWN
-
Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions
NCT04782596 ·Status: COMPLETED ·Phase: NA
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
The TMS Treatment for Postoperative Headache in GH Tumor
NCT04529356 ·Status: UNKNOWN ·Phase: NA
-
Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet
NCT02049671 ·Status: UNKNOWN
-
Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
NCT01459237 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
NCT06679816 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery
NCT06448195 ·Status: RECRUITING ·Phase: PHASE4
-
Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
NCT02632084 ·Status: COMPLETED
-
Acute Application of Pegvisomant and Octreotide in Acromegaly
NCT00595140 ·Status: COMPLETED ·Phase: PHASE4
-
Pasireotide Therapy in Patients With Nelson's Syndrome
NCT01617733 ·Status: TERMINATED ·Phase: PHASE2
-
Pituitary Adenoma and Serum Lipid
NCT04021212 ·Status: UNKNOWN
-
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308 ·Status: TERMINATED
-
Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors
NCT02629926 ·Status: UNKNOWN